No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MASS 908 Devices
- 5.810
- -0.130-2.19%
Close Jun 14 16:00 ET
- 5.860
- +0.050+0.86%
Post 19:04 ET
200.36MMarket Cap-5429P/E (TTM)
5.950High5.730Low227.70KVolume5.930Open5.940Pre Close1.33MTurnover0.87%Turnover RatioLossP/E (Static)34.49MShares12.51052wk High1.28P/B152.06MFloat Cap4.85052wk Low--Dividend TTM26.17MShs Float79.600Historical High--Div YieldTTM3.70%Amplitude4.850Historical Low5.826Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Should You Hold 908 Devices (MASS)?
908 Devices to Participate in Upcoming Investor Conferences
908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. 2024 Leerink
12 Information Technology Stocks Moving In Tuesday's After-Market Session
GainersGenasys (NASDAQ:GNSS) stock rose 10.0% to $2.2 during Tuesday's after-market session. The company's market cap stands at $96.8 million. As per the news, the Q2 earnings report came out today. A
908 Devices(MASS.US) Officer Buys US$64,200 in Common Stock
$908 Devices(MASS.US)$ Officer Knopp Kevin J. purchased 10,000 shares of common stock on May 13, 2024 at an average price of $6.42 for a total value of $64,200.Source: Announcement What is statement o
908 Devices Price Target Maintained With a $14.00/Share by Stephens & Co.
908 Devices Price Target Maintained With a $14.00/Share by Stephens & Co.
Express News | Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target
Comments
$908 Devices(MASS.US$
NEWS
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
NEWS
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
$908 Devices(MASS.US$ 🐂CFO loaded 🛶
Investors expect 908 Devices to overcome its recent revenue decline, as indicated by its high P/S ratio. Despite a drop in revenue, the firm shows a promising business trajectory over the previous three years and is projected to grow faster than the industry, justifying high P/S.
Follow for daily watchlist 🚀
$Akamai(AKAM.US$ $Bruush Oral Care(BRSH.US$ $Extra Space Storage Inc(EXR.US$ $INVO Bioscience(INVO.US$ $Leju Holdings(LEJU.US$ $908 Devices(MASS.US$ $Marqeta(MQ.US$ $Penn Entertainment(PENN.US$ $Proterra(PTRA.US$ $Salarius Pharmaceuticals(SLRX.US$ $Super Micro Computer(SMCI.US$ $Tango Therapeutics(TNGX.US$ $Thoughtworks(TWKS.US$ $Twilio(TWLO.US$ $Wynn Resorts(WYNN.US$
$Akamai(AKAM.US$ $Bruush Oral Care(BRSH.US$ $Extra Space Storage Inc(EXR.US$ $INVO Bioscience(INVO.US$ $Leju Holdings(LEJU.US$ $908 Devices(MASS.US$ $Marqeta(MQ.US$ $Penn Entertainment(PENN.US$ $Proterra(PTRA.US$ $Salarius Pharmaceuticals(SLRX.US$ $Super Micro Computer(SMCI.US$ $Tango Therapeutics(TNGX.US$ $Thoughtworks(TWKS.US$ $Twilio(TWLO.US$ $Wynn Resorts(WYNN.US$
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg